Clinical Trial Update: Patient Research Cohort: Rapidly Evolving Multiple Sclerosis

View source ↗

Summary

A completed clinical trial update from Imperial College London on a patient research cohort for Relapsing-remitting and Secondary Progressive Multiple Sclerosis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Progressive Multiple Sclerosis
• Relapsing-remitting Multiple Sclerosis

Snippet

Sponsor: Imperial College London | Conditions: Relapsing-remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis | Status: COMPLETED | Results posted: 2021-03-08